Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Cetuximab Recombinant Human Monoclonal Antibody (C225 (Cetuximab))
GREENER_CHOICE

Catalog No. PIMA547859
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIMA547859 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIMA547859 Supplier Invitrogen™ Supplier No. MA547859
Add to Cart
Add to Cart

Human Recombinant Monoclonal Antibody

Specificity: Recognises human EGFR.

Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Cetuximab
Applications ELISA, Flow Cytometry, Inhibition Assays, Immunohistochemistry (Paraffin)
Classification Recombinant Monoclonal
Clone C225 (Cetuximab)
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.02% ProClin 300
Gene CD4
Gene Accession No. P01730
Gene Alias Erbitux; Fab C225; IMC-225
Host Species Human
Immunogen human EGFR.
Purification Method Protein A
Quantity 200 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 920
Target Species Human
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.